Metoprolol tachycardia dosage
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Dosage for Tachycardia: Insights from Research
Introduction to Metoprolol and Tachycardia
Metoprolol, a beta-adrenergic blocker, is widely used to manage various types of tachycardia, including exercise-induced tachycardia, multifocal atrial tachycardia (MAT), and ventricular tachyarrhythmias. This article synthesizes research findings on the effective dosages of metoprolol for different types of tachycardia.
Metoprolol Dosage for Exercise-Induced Tachycardia
Research comparing the effects of different dosages of metoprolol on exercise-induced tachycardia indicates that while lower doses (50, 100, and 200 mg) are effective shortly after administration, their effects diminish significantly after 24 hours. A higher dose of 400 mg was required to maintain a reduction in exercise tachycardia at 24 hours, although its efficacy was still less than that of atenolol and sotalol at equivalent doses .
Metoprolol for Multifocal Atrial Tachycardia (MAT)
Studies have shown that metoprolol is effective in managing MAT, particularly in patients with severe cardiopulmonary illness. Oral doses averaging 32.5 mg and intravenous doses averaging 6.5 mg resulted in significant heart rate reduction and conversion to sinus rhythm in a majority of patients. The response time was faster with intravenous administration, averaging less than 10 minutes compared to 5.1 hours with oral administration 27.
Metoprolol in Acute Myocardial Infarction and Ventricular Tachyarrhythmias
In patients with acute myocardial infarction, metoprolol administered intravenously (15 mg) followed by an oral dose (200 mg daily) significantly reduced the incidence of ventricular fibrillation and the need for antiarrhythmic drugs like lidocaine. However, it did not affect the occurrence of less serious ventricular tachyarrhythmias 39. Another study confirmed that metoprolol (200 mg/day) effectively suppressed complex ventricular arrhythmias, including premature ventricular beats and exercise-induced ventricular tachycardia .
Intravenous Metoprolol for Supraventricular Tachyarrhythmias
Intravenous metoprolol, administered at doses ranging from 2 to 15 mg, has been shown to effectively control ventricular rates in patients with various supraventricular tachyarrhythmias, including atrial fibrillation and supraventricular tachycardia. The mean ventricular rate decreased significantly within 10 minutes of administration, with effects lasting up to several hours. Hypotension was noted as a transient side effect in some patients .
Metoprolol for Fetal Supraventricular Tachycardia
Metoprolol has also been used successfully in treating fetal supraventricular tachycardia (SVT) refractory to other treatments. In cases where flecainide monotherapy failed, adding metoprolol (50 mg three times/day) resulted in conversion to sinus rhythm within days, with no significant maternal side effects .
Conclusion
Metoprolol is a versatile beta-blocker effective in managing various forms of tachycardia. Dosages vary depending on the type and severity of tachycardia, with higher doses required for sustained effects in exercise-induced tachycardia and lower doses effective for MAT and acute myocardial infarction. Intravenous administration provides rapid control in acute settings, while oral administration is suitable for ongoing management.
Sources and full results
Most relevant research papers on this topic